Literature DB >> 6316641

Mechanism of interferon action: human leukocyte and immune interferons regulate the expression of different genes and induce different antiviral states in human amnion U cells.

C E Samuel, G S Knutson.   

Abstract

The inhibition of virus replication and the induction of protein phosphorylation were examined in human amnion U and human fibroblast GM2767A cells treated with highly purified cloned human leukocyte and immune interferons synthesized in Escherichia coli. Both leukocyte interferon (IFN-alpha A) and immune interferon (IFN-gamma) possessed antiviral activity as measured by the single cycle yield reduction of vesicular stomatitis virus (VSV) in the human U and GM2767A cell lines. By contrast, only IFN-gamma and not IFN-alpha A inhibited the single cycle replication of reovirus in U and GM2767A cells. IFN-alpha A, but not IFN-gamma, efficiently induced the double-stranded RNA-dependent phosphorylation of the ribosome-associated protein P1 and the alpha subunit of protein synthesis initiation factor eIF-2 in U cells. However, neither IFN-alpha A nor IFN-gamma induced the phosphorylation of P1 and eIF-2 alpha in GM2767A cells. The antiviral activities of IFN-alpha A and IFN-gamma were synergistic for the inhibition of VSV but not for the inhibition of reovirus or the induction of protein phosphorylation. These results suggest that human leukocyte and immune interferons differentially regulate the expression of certain genes and induce mechanistically distinct antiviral states in human cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6316641     DOI: 10.1016/0042-6822(83)90101-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  The Lang strain of reovirus serotype 1 and the Dearing strain of reovirus serotype 3 differ in their sensitivities to beta interferon.

Authors:  B L Jacobs; R E Ferguson
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

2.  Loss of (2'-5')oligoadenylate synthetase activity by production of antisense RNA results in lack of protection by interferon from viral infections.

Authors:  A De Benedetti; B A Pytel; C Baglioni
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

Review 3.  Alpha interferon: a look to the future.

Authors:  E M Bonnem
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

4.  Adenovirus early region 1A modulation of interferon antiviral activity.

Authors:  K P Anderson; E H Fennie
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

5.  Mechanism of interferon action: alpha and gamma interferons differentially affect mRNA levels of the catalytic subunit of protein kinase A and protein Mx in human cells.

Authors:  D C Thomas; C E Samuel
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

6.  Tissue selectivity of interferon-stimulated gene expression in mice infected with Dam(+) versus Dam(-) Salmonella enterica serovar Typhimurium strains.

Authors:  Ronit Shtrichman; Douglas M Heithoff; Michael J Mahan; Charles E Samuel
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  Protein kinase PKR-dependent activation of mitogen-activated protein kinases occurs through mitochondrial adapter IPS-1 and is antagonized by vaccinia virus E3L.

Authors:  Ping Zhang; Jeffrey O Langland; Bertram L Jacobs; Charles E Samuel
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

8.  Organization of the mouse RNA-specific adenosine deaminase Adar1 gene 5'-region and demonstration of STAT1-independent, STAT2-dependent transcriptional activation by interferon.

Authors:  Cyril X George; Sonali Das; Charles E Samuel
Journal:  Virology       Date:  2008-09-06       Impact factor: 3.616

9.  Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication.

Authors:  N Harris; R M Buller; G Karupiah
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

10.  Transcription-based prediction of response to IFNbeta using supervised computational methods.

Authors:  Sergio E Baranzini; Parvin Mousavi; Jordi Rio; Stacy J Caillier; Althea Stillman; Pablo Villoslada; Matthew M Wyatt; Manuel Comabella; Larry D Greller; Roland Somogyi; Xavier Montalban; Jorge R Oksenberg
Journal:  PLoS Biol       Date:  2004-12-28       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.